Ausdal Financial Partners, Inc. Organon & Co. Transaction History
Ausdal Financial Partners, Inc.
- $1.25 Billion
- Q1 2025
A detailed history of Ausdal Financial Partners, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 15,675 shares of OGN stock, worth $141,702. This represents 0.02% of its overall portfolio holdings.
Number of Shares
15,675Holding current value
$141,702% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding OGN
# of Institutions
805Shares Held
198MCall Options Held
1.84MPut Options Held
1.41M-
Black Rock Inc. New York, NY32.6MShares$295 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$269 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.7MShares$96.9 Million0.06% of portfolio
-
State Street Corp Boston, MA8.98MShares$81.2 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL7.98MShares$72.1 Million0.29% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $2.3B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...